Aurobindo Pharma Limited (NSE:AUROPHARMA)
India · Delayed Price · Currency is INR 1,253.80
+22.50 (1.83%)
Jan 7, 2026, 9:40 AM IST
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 715.14 billion as of January 6, 2026. Its market cap has increased by 1.45% in one year.
Market Cap
715.14B
Enterprise Value
704.09B
Revenue
325.14B
Ranking
n/a
PE Ratio
20.90
Stock Price
1,253.80
Market Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 715.14B, an increase of 7,346.85%. That is a compound annual growth rate of 20.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 701.26B | 2.06% |
| Dec 31, 2025 | 687.09B | -11.35% |
| Dec 31, 2024 | 775.08B | 22.03% |
| Dec 29, 2023 | 635.16B | 147.32% |
| Dec 30, 2022 | 256.82B | -40.31% |
| Dec 31, 2021 | 430.28B | -20.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.15T |
| Divi's Laboratories | 1.70T |
| Cipla | 1.22T |
| Apollo Hospitals Enterprise | 1.03T |
| Zydus Lifesciences | 922.62B |
| Mankind Pharma | 909.29B |
| Fortis Healthcare | 690.60B |
| Alkem Laboratories | 668.67B |